VRTX Covered Call Analysis: Proceed With Caution Weak ยท 35/100

Vertex Pharmaceuticals Inc (Healthcare) ยท $515.02 ยท Analysis generated Nov 20, 2026 ยท Data as of market close Nov 20
This strategy is NOT recommended for VRTX right now
Score 35/100. The technical signals do not support selling covered calls on VRTX at this time. IV -58% vs avg โ€” premiums below average, less income. MACD bearish โ€” stock may keep falling (risk). TTM Squeeze ON โ€” breakout imminent, risky for capped strategies. Check back when conditions improve, or consider a different strategy.

Quick Take

VRTX is trading at $515.02 with RSI at 43 (neutral territory). Options IV is at 33% โ€” 58% below its 30-day average of 79%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.

Technical Signals

RSI (14)
43
IV Today
33.1%
IV vs 30d Avg
-58%
MACD
bearish
ADX
11
MFI
48

The Setup

VRTX Covered Call

LONG STOCK
100 shares @ $515.02
SHORT CALL
$560 Jan '27 ยท $24.0/sh
Net Cost
$49,102
Max Profit
+$6,898
Break-even
$491.02
Projected P&L at Target
+$6,520 (13.3%)
P&L at Expiry Now $515 $361 $515 $670

P&L Scenarios

What happens at different VRTX prices by expiry:

VRTX Price Today +3d (Nov 24) +7d (Nov 28) Dec 9 Dec 27 Jan 15 (exp)
$412 (-20%) -$8,144 -$8,113 -$8,074 -$7,984 -$7,906 -$7,900
$438 (-15%) -$5,824 -$5,774 -$5,709 -$5,545 -$5,358 -$5,325
$464 (-10%) -$3,667 -$3,595 -$3,500 -$3,242 -$2,873 -$2,750
$489 (-5%) -$1,715 -$1,622 -$1,496 -$1,138 -$535 -$175
$505 (-2%) -$656 -$552 -$409 +$4 +$752 +$1,370
$515 (0%) โ† now -$0 +$112 +$264 +$709 +$1,547 +$2,400
$525 (+2%) +$616 +$733 +$894 +$1,367 +$2,283 +$3,430
$541 (+5%) +$1,464 +$1,588 +$1,758 +$2,263 +$3,270 +$4,975
$556 (+8%) โ† target +$2,221 +$2,349 +$2,525 +$3,050 +$4,107 +$6,520
$567 (+10%) +$2,677 +$2,806 +$2,984 +$3,514 +$4,581 +$6,898
$592 (+15%) +$3,654 +$3,783 +$3,958 +$4,478 +$5,494 +$6,898
$618 (+20%) +$4,422 +$4,543 +$4,709 +$5,190 +$6,076 +$6,898

Why This Strategy, Why Now

  • RSI at 43
  • IV -58% vs avg โ€” premiums below average, less income
  • MACD bearish โ€” stock may keep falling (risk)
  • ADX at 11 โ€” range-bound, perfect for selling calls
  • TTM Squeeze ON โ€” breakout imminent, risky for capped strategies

Key Risks

TTM Squeeze is ON โ€” a volatility breakout may be imminent. If the breakout is to the upside, your short call will be tested quickly.